Total Payments
$3,488
2024 Payments
$676.15
Companies
37
Transactions
129
Medicare Patients
8,037
Medicare Billing
$783,328
Payment Breakdown by Category
Food & Beverage$3,374 (96.7%)
Education$113.97 (3.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,374 | 127 | 96.7% |
| Education | $113.97 | 2 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| COLOPLAST CORP | $780.14 | 11 | $0 (2024) |
| Boston Scientific Corporation | $523.23 | 11 | $0 (2023) |
| Astellas Pharma US Inc | $353.37 | 22 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $272.07 | 15 | $0 (2024) |
| NeoTract Inc. | $163.98 | 1 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $123.06 | 1 | $0 (2017) |
| Myovant Sciences Inc. | $122.18 | 8 | $0 (2022) |
| ABBVIE INC. | $108.28 | 7 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $106.13 | 5 | $0 (2024) |
| Photocure Inc | $102.82 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $676.15 | 27 | COLOPLAST CORP ($181.28) |
| 2023 | $672.21 | 32 | Astellas Pharma US Inc ($192.21) |
| 2022 | $671.25 | 24 | Boston Scientific Corporation ($384.92) |
| 2021 | $233.30 | 15 | Astellas Pharma US Inc ($88.94) |
| 2020 | $125.68 | 8 | Blue Earth Diagnostics Limited ($52.38) |
| 2019 | $310.41 | 6 | Coloplast Corp ($160.93) |
| 2018 | $264.32 | 7 | Coloplast Corp ($146.90) |
| 2017 | $534.46 | 10 | NeoTract Inc. ($163.98) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Oncology | ||||||
| 12/05/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/21/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $14.26 | General |
| 11/13/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: UROLOGY | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: HORMONE THERAPY | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/10/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Integra LifeSciences Corporation | OMNIGRAFT (Device), Integra, Integra | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Recon-Skin and Wound | ||||||
| 09/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: HORMONE THERAPY | ||||||
| 09/04/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: HORMONE THERAPY | ||||||
| 07/25/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: ONCOLOGY | ||||||
| 07/19/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Oncology | ||||||
| 05/10/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/08/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: HORMONE THERAPY | ||||||
| 05/05/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $118.78 | General |
| Category: Men's Health | ||||||
| 04/24/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $18.46 | General |
| 04/19/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $62.50 | General |
| Category: Men's Health | ||||||
| 04/10/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: ONCOLOGY | ||||||
| 04/04/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/01/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Oncology | ||||||
| 02/09/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,757 | 2,552 | $486,887 | $172,267 |
| 2022 | 22 | 1,981 | 2,728 | $613,455 | $200,109 |
| 2021 | 24 | 2,301 | 3,148 | $658,735 | $219,720 |
| 2020 | 23 | 1,998 | 2,823 | $630,111 | $191,232 |
Total Patients
8,037
Total Services
11,251
Medicare Billing
$783,328
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 452 | 783 | $184,090 | $73,619 | 40.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 73 | 85 | $48,875 | $16,188 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 156 | 192 | $30,777 | $13,144 | 42.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 59 | 85 | $26,690 | $11,840 | 44.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 65 | 69 | $18,975 | $9,624 | 50.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $21,948 | $8,182 | 37.3% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 25 | 25 | $20,500 | $6,206 | 30.3% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 63 | 69 | $23,391 | $5,852 | 25.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 55 | $7,095 | $5,092 | 71.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 12 | 12 | $15,600 | $4,056 | 26.0% |
| 51710 | Complicated change of bladder tube | Office | 2023 | 11 | 36 | $14,184 | $3,710 | 26.2% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 62 | 67 | $11,591 | $2,538 | 21.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 15 | 17 | $17,748 | $2,219 | 12.5% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 11 | 24 | $5,904 | $1,709 | 29.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 138 | 185 | $7,585 | $1,500 | 19.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 430 | 686 | $6,860 | $1,499 | 21.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,262 | $1,224 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $5,720 | $1,085 | 19.0% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 17 | 25 | $4,625 | $1,079 | 23.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 16 | 16 | $7,328 | $824.28 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 15 | $3,255 | $665.81 | 20.5% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 15 | 17 | $884.00 | $408.37 | 46.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 475 | 773 | $181,880 | $71,264 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 228 | 297 | $47,920 | $19,727 | 41.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 80 | 93 | $53,475 | $17,850 | 33.4% |
About Frank Burks
Frank Burks is a Urology healthcare provider based in Royal Oak, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659585198.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Frank Burks has received a total of $3,488 in payments from pharmaceutical and medical device companies, with $676.15 received in 2024. These payments were reported across 129 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,374).
As a Medicare-enrolled provider, Burks has provided services to 8,037 Medicare beneficiaries, totaling 11,251 services with total Medicare billing of $783,328. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Royal Oak, MI
- Active Since 05/10/2007
- Last Updated 07/16/2015
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1659585198
Products in Payments
- Titan (Device) $344.35
- TITAN (Device) $320.80
- ORGOVYX (Drug) $308.41
- Urolift - UL400 (Device) $163.98
- rezum Generator (Device) $152.62
- DARZALEX (Biological) $123.06
- General - Erectile Dysfunction (Device) $122.91
- Xtandi (Drug) $121.09
- AMS (Device) $111.77
- AMS Ambicor (Device) $109.39
- ADSTILADRIN (Biological) $106.13
- PENILE RECONSTRUCTION (Device) $87.37
- GEMTESA (Drug) $85.84
- Axumin (Drug) $76.19
- Cysview (Drug) $71.16
- Olympus Laser Devices (Device) $68.39
- Androgel (Drug) $65.34
- XTANDI (Drug) $64.83
- Noctiva (Drug) $60.85
- NOCDURNA (Drug) $53.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Royal Oak
Richard Bennett, Md, MD
Urology — Payments: $607,905
Urology $607,905
Dr. Kenneth Peters, Md, MD
Urology — Payments: $26,596
Urology $26,596
Adam Gadzinski, M.d, M.D
Urology — Payments: $18,520
Urology $18,520
Dr. Jason Gilleran, Md, MD
Urology — Payments: $14,239
Urology $14,239
Melissa Fischer, Md, MD
Urology — Payments: $11,402
Urology $11,402
Dr. Hamza Beano, M.d, M.D
Urology — Payments: $8,264
Urology $8,264